Author

Chin-Lun Huang

Observed name: Chin‐Lun Huang

Institution: Boehringer Ingelheim (Taiwan)

Observed institutions: Memorial Sloan Kettering Cancer Center, National Taiwan University, Boehringer Ingelheim (Taiwan), National Taiwan University Hospital

OpenAlex ID: A5113782408

Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy

2008 · Chih-Hsin Yang, Chong-Jen Yu, et al. · Journal of Clinical Oncology · 235

EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment

2008 · Chin-Lun Huang, Chih-Hsin Yang, et al. · Lung Cancer · 48

HER‐2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti‐HER‐2/neu regulation of cell growth and chemosensitivity

2002 · Chiun Hsu, Chin‐Lun Huang, et al. · Cancer · 44

Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer

2009 · Hui-Ju Ch’ang, Chin-Lun Huang, et al. · Cancer Chemotherapy and Pharmacology · 25

Combination of 13-cis Retinoic Acid and Interferon-α in the Treatment of Recurrent or Refractory Peripheral T-cell Lymphoma

2002 · Chin-Lun Huang, Zhong-Zhe Lin, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7

XENERA-1: A phase II trial of xentuzumab (Xe) in combination with everolimus (Ev) and exemestane (Ex) in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC) and non-visceral involvement.

2019 · Peter Schmid, Hope S. Rugo, et al. · Journal of Clinical Oncology · 3

Growth inhibitory and chemosensitizing effects of chemotherapeutic agents by ZD6474 (vandetanib) in human gastric cancer cells

2008 · Kun‐Huei Yeh, Hsun-Fang Fan, et al. · Cancer Research

Works count: 7

Citation count: 362

H-index: 5

I10-index: 4